WATERS CORP /DE/ 8-K

What Happened

• Waters Corporation furnished an investor presentation (Exhibit 99.1) for the J.P. Morgan Healthcare Conference on January 12, 2026. The presentation and subsequent Q&A include high‑level commentary on the company’s business performance; a transcript will be posted on Waters’ website (waters.com) in the Investors → Events & Presentations section. The information in the 8‑K was furnished (not “filed”) under Regulation FD and is therefore not subject to certain Exchange Act liabilities.

Key Details

• Presentation date: January 12, 2026; furnished as Exhibit 99.1 to the Form 8‑K.
• In connection with the proposed transaction among Waters, Augusta SpinCo Corporation (“SpinCo”) and Becton, Dickinson and Company (“BD”): the Form S‑4 was declared effective by the SEC on December 23, 2025 and the definitive proxy statement/prospectus was mailed to Waters shareholders on or about December 23, 2025 (record date December 19, 2025).
• The Form 10 for SpinCo was declared effective on December 31, 2025.
• Investors are urged to read the Form S‑4/definitive proxy/prospectus, the information statement and other SEC filings (available at sec.gov and on Waters’ and BD’s investor websites) for full details; Waters, BD and their officers/directors may be participants in the solicitation.

Why It Matters

• The presentation provides a timely, public update from Waters management on business performance and serves as part of the communications around the proposed Waters/BD/SpinCo transaction. For shareholders, the related S‑4, proxy/prospectus and Form 10 contain the material details, risks and voting information needed to evaluate the transaction and any related votes. Investors should review those filings and company materials before making investment or voting decisions.